. Depression may adversely impact prognosis in CAD patients 4 , but little is known about depression and prognosis in PAD. Therefore, we read with great interest the work of Cherr and colleagues 5 on the relation between psychological factors and cardiovascular events in PAD. Their study generated interesting findings, but there are also a number of issues we would like to address here. First, the screening method the authors used probably led to an overestimation of depression rates. The General Health Questionnaire is not a depression scale, but rather was developed to assess non-specific psychological distress in community samples 6 , and a higher cut-off score (≥8) has been recommended to screen for depressive symptoms in patients with chronic somatic disease 7 .
Second, 80% of depressed patients received antidepressant therapy. Analyses were not adjusted for type of antidepressant, while studies warn against the use tricyclic antidepressants in cardiovascular populations because they are associated with an increased risk of myocardial infarction 8, 9 . Therefore, we cannot rule out the influence of antidepressant use on adverse outcomes in depressed patients. Finally, in the adjusted analyses, only a rough parameter of disease severity was included (indication for intervention). Table 2 shows us that the group that underwent revascularization was very heterogeneous in terms of disease severity; indication for intervention ranged from claudication to critical leg ischemia and gangrene or tissue loss. It would have been more appropriate to include the lowest ankle-brachial index in the adjusted analyses due to its strong prognostic value for adverse cardiovascular events in PAD 10 . Likewise, in CAD, the relation between depression and increased risk of mortality seems to be confounded by cardiac disease severity or left ventricular dysfunction 11 . Future studies examining the link between psychological factors and prognosis in PAD need to take into account reliable indices of disease severity.
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